Skip to main content
Log in

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Yazer MH, Triulzi DJ . Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007; 14: 664–670.

    Article  PubMed  Google Scholar 

  2. Horn B, Viele M, Mentzer W, Mogck N, DeSantes K, Cowan M . Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 1999; 24: 1009–1013.

    Article  CAS  PubMed  Google Scholar 

  3. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177–181.

    CAS  PubMed  Google Scholar 

  4. Toren A, Dacosta Y, Manny N, Varadi G, Or R, Nagler A . Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood 1996; 87: 843–844.

    CAS  PubMed  Google Scholar 

  5. Panaro F, DeChristopher PJ, Rondelli D, Testa G, Sankary H, Popescu M et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant 2004; 18: 332–335.

    Article  CAS  PubMed  Google Scholar 

  6. Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA et al. Post transplant immune-mediated hemolysis. Transfusion 2002; 42: 198–204.

    Article  PubMed  Google Scholar 

  7. de Lima M, Champlin RE, Thall PF, Wang X, Martin III TG, Cook JD et al. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia 2007.

  8. Gajewski JL, Petz LD, Calhoun L, O’Rourke S, Landaw EM, Lyddane NR et al. Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992; 79: 3076–3085.

    CAS  PubMed  Google Scholar 

  9. Corti P, Bonanomi S, Vallinoto C, Balduzzi A, Uderzo C, Cazzaniga G et al. Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation. Acta Haematol 2003; 109: 43–45.

    Article  CAS  PubMed  Google Scholar 

  10. Ship A, May W, Lucas K . Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation. Bone Marrow Transplant 2002; 29: 365–366.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S O Ciurea.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H., Gulbis, A., De Padua Silva, L. et al. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Bone Marrow Transplant 42, 67–69 (2008). https://doi.org/10.1038/bmt.2008.79

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.79

  • Springer Nature Limited

This article is cited by

Navigation